LBX2-AS1
gene geneOn this page
Summary
LBX2-AS1 (LBX2 antisense RNA 1, HGNC:25136) is a long non-coding RNA gene on chromosome 2p13.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25136 |
| Approved symbol | LBX2-AS1 |
| Name | LBX2 antisense RNA 1 |
| Location | 2p13.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000257702 |
| Ensembl biotype | lncRNA |
| Entrez | 151534 |
| RNAcentral | URS0000CCE0BA — lncRNA, 2473 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 14 lncRNA
ENST00000548978, ENST00000603175, ENST00000688827, ENST00000693462, ENST00000734461, ENST00000734462, ENST00000734463, ENST00000734464, ENST00000734465, ENST00000734466, ENST00000734467, ENST00000734468, ENST00000734469, ENST00000734470
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000548978 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002372867 | 74503640 | 74504678 |
| ENSE00002391627 | 74502595 | 74503407 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 87.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.4280 / max 67.2881, expressed in 1290 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21041 | 2.2509 | 758 |
| 21035 | 1.0041 | 479 |
| 21037 | 0.7946 | 486 |
| 21040 | 0.7570 | 469 |
| 21039 | 0.3041 | 143 |
| 21042 | 0.1784 | 86 |
| 21036 | 0.1005 | 39 |
| 21038 | 0.0385 | 8 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 87.25 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.49 | gold quality |
| pancreatic ductal cell | CL:0002079 | 84.97 | silver quality |
| liver | UBERON:0002107 | 80.73 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 79.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.81 | gold quality |
| duodenum | UBERON:0002114 | 77.36 | gold quality |
| kidney epithelium | UBERON:0004819 | 75.84 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 75.33 | gold quality |
| jejunal mucosa | UBERON:0000399 | 75.09 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 75.09 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.48 | gold quality |
| small intestine | UBERON:0002108 | 74.43 | gold quality |
| body of stomach | UBERON:0001161 | 74.42 | gold quality |
| monocyte | CL:0000576 | 74.17 | gold quality |
| leukocyte | CL:0000738 | 74.16 | gold quality |
| granulocyte | CL:0000094 | 73.77 | gold quality |
| transverse colon | UBERON:0001157 | 73.39 | gold quality |
| omental fat pad | UBERON:0010414 | 73.33 | gold quality |
| peritoneum | UBERON:0002358 | 73.24 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 72.82 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 72.66 | gold quality |
| apex of heart | UBERON:0002098 | 72.64 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 72.19 | gold quality |
| stomach | UBERON:0000945 | 71.65 | gold quality |
| rectum | UBERON:0001052 | 71.35 | gold quality |
| body of pancreas | UBERON:0001150 | 70.60 | gold quality |
| spleen | UBERON:0002106 | 70.23 | gold quality |
| tibial nerve | UBERON:0001323 | 70.13 | gold quality |
| adipose tissue | UBERON:0001013 | 70.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.44 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 12)
- LncRNA LBX2-AS1 promoted cell migration and epithelial-mesenchymal transition process in esophageal squamous cell carcinoma. LBX2-AS1 interacting with HNRNPC to promote ZEB1/2 mRNA stability. (PMID:30824187)
- LBX2-AS1 might be associated with periodontitis (PMID:31512745)
- Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer. (PMID:31539129)
- LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer. (PMID:31673844)
- LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop. (PMID:32559617)
- ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis. (PMID:33099720)
- Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3beta pathway in vitro. (PMID:33637977)
- Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer. (PMID:33733923)
- Long noncoding RNA LBX2-AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression. (PMID:35253306)
- Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway. (PMID:35816228)
- The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility. (PMID:36131071)
- LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy. (PMID:38326905)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.